| Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised … MS Hofman, N Lawrentschuk, RJ Francis, C Tang, I Vela, P Thomas, ... The Lancet 395 (10231), 1208-1216, 2020 | 2091 | 2020 |
| Sensitivity, specificity, and predictors of positive 68Ga–prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and … M Perera, N Papa, D Christidis, D Wetherell, MS Hofman, DG Murphy, ... European urology 70 (6), 926-937, 2016 | 1235 | 2016 |
| Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution … M Perera, N Papa, M Roberts, M Williams, C Udovicich, I Vela, ... European urology 77 (4), 403-417, 2020 | 1017 | 2020 |
| Epidemiology of bladder cancer in 2023: a systematic review of risk factors I Jubber, S Ong, L Bukavina, PC Black, E Comperat, AM Kamat, ... European urology 84 (2), 176-190, 2023 | 472 | 2023 |
| The role of focal therapy in the management of localised prostate cancer: a systematic review M Valerio, HU Ahmed, M Emberton, N Lawrentschuk, M Lazzeri, ... European urology 66 (4), 732-751, 2014 | 466 | 2014 |
| The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the … L Emmett, J Buteau, N Papa, D Moon, J Thompson, MJ Roberts, K Rasiah, ... European urology 80 (6), 682-689, 2021 | 421 | 2021 |
| Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations ED Crawford, A Heidenreich, N Lawrentschuk, B Tombal, ACL Pompeo, ... Prostate cancer and prostatic diseases 22 (1), 24-38, 2019 | 415 | 2019 |
| Stereotactic abative body radiotherapy (SABR) for oligometastatic prostate cancer: a prospective clinical trial S Siva, M Bressel, DG Murphy, M Shaw, S Chander, J Violet, KH Tai, ... European urology 74 (4), 455-462, 2018 | 345 | 2018 |
| Prevention and management of complications following radical cystectomy for bladder cancer N Lawrentschuk, R Colombo, OW Hakenberg, SP Lerner, W Månsson, ... European urology 57 (6), 983-1001, 2010 | 329 | 2010 |
| Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? JP Grummet, M Weerakoon, S Huang, N Lawrentschuk, M Frydenberg, ... BJU international 114 (3), 384-388, 2014 | 315 | 2014 |
| Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies LM Cher, C Murone, N Lawrentschuk, S Ramdave, A Papenfuss, ... Journal of Nuclear Medicine 47 (3), 410-418, 2006 | 250 | 2006 |
| ‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging N Lawrentschuk, MA Haider, N Daljeet, A Evans, A Toi, A Finelli, ... BJU international 105 (9), 1231-1236, 2010 | 239 | 2010 |
| The role of magnetic resonance imaging in the diagnosis and management of prostate cancer J Thompson, N Lawrentschuk, M Frydenberg, L Thompson, P Stricker, ... BJU international 112, 6-20, 2013 | 227 | 2013 |
| 68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review J Corfield, M Perera, D Bolton, N Lawrentschuk World journal of urology 36 (4), 519-527, 2018 | 224 | 2018 |
| The social media revolution is changing the conference experience: analytics and trends from eight international meetings SE Wilkinson, MY Basto, G Perovic, N Lawrentschuk, DG Murphy BJU international 115 (5), 839-846, 2015 | 214 | 2015 |
| Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study D Margel, SA Yap, N Lawrentschuk, L Klotz, M Haider, K Hersey, A Finelli, ... The Journal of urology 187 (4), 1247-1252, 2012 | 199 | 2012 |
| Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy U Lindner, N Lawrentschuk, RA Weersink, SRH Davidson, O Raz, ... European urology 57 (6), 1111-1114, 2010 | 198 | 2010 |
| Carbon footprint in flexible ureteroscopy: a comparative study on the environmental impact of reusable and single-use ureteroscopes NF Davis, S McGrath, M Quinlan, G Jack, N Lawrentschuk, DM Bolton Journal of endourology 32 (3), 214-217, 2018 | 195 | 2018 |
| Landmarks in prostate cancer NJ Sathianathen, BR Konety, J Crook, F Saad, N Lawrentschuk Nature Reviews Urology 15 (10), 627-642, 2018 | 189 | 2018 |
| Transperineal biopsy of the prostate—is this the future? DTS Chang, B Challacombe, N Lawrentschuk Nature Reviews Urology 10 (12), 690-702, 2013 | 187 | 2013 |
Damien BoltonUniversity of MelbourneVerified email at unimelb.edu.au
